FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Golembo Myriam

 2. Date of Event Requiring Statement (MM/DD/YYYY)
10/28/2019 

 3. Issuer Name and Ticker or Trading Symbol

BiomX Inc. [PHGE]

(Last)        (First)        (Middle)

C/O BIOMX LTD., 7 PINHAS SAPIR ST. FLOOR 2

 4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                          _____ 10% Owner
___X___ Officer (give title below)        _____ Other (specify below)
Vice President of Development /

(Street)

NESS ZIONA, L3 7414002      

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed(MM/DD/YYYY)

 

6. Individual or Joint/Group Filing(Check Applicable Line)

_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person


Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)		2. Amount of Securities Beneficially Owned
(Instr. 4)		3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)		4. Nature of Indirect Beneficial Ownership
(Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)		2. Date Exercisable and Expiration Date
(MM/DD/YYYY)		3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)		4. Conversion or Exercise Price of Derivative Security5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)		6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Common Stock Options - Right to Buy  (1)6/25/2027 Common Stock Options 38841 $1.69 D  
Common Stock Options - Right to Buy  (2)6/27/2028 Common Stock Options 7480 $1.97 D  
Common Stock Options - Right to Buy  (3)3/29/2029 Common Stock Options 29678 $2.03 D  
Explanation of Responses:
(1) 25% of these options vested on June 25, 2018. Thereafter, the remaining options shall vest in 12 equal quarterly installments over three years. As of the reporting date, options to purchase 16,993 shares of common stock were unvested.
(2) 25% of these options vested on June 27, 2019. Thereafter, the remaining options shall vest in 12 equal quarterly installments over three years. As of the reporting date, options to purchase 5,145 shares of common stock were unvested.
(3) 25% of these options shall vest on March 29, 2020. Thereafter, the remaining options shall vest in 12 equal quarterly installments over three years. As of the reporting date, options to purchase 29,678 shares of common stock were unvested.
Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
Golembo Myriam
C/O BIOMX LTD.
7 PINHAS SAPIR ST. FLOOR 2
NESS ZIONA, L3 7414002

Vice President of Development
Signatures
/s/ Myriam Golembo11/1/2019
**Signature of Reporting PersonDate
Chardan Healthcare Acqui... (AMEX:CHAC)
Historical Stock Chart
Von Apr 2024 bis Mai 2024 Click Here for more Chardan Healthcare Acqui... Charts.
Chardan Healthcare Acqui... (AMEX:CHAC)
Historical Stock Chart
Von Mai 2023 bis Mai 2024 Click Here for more Chardan Healthcare Acqui... Charts.